Osteonecrosis of the Jaw Clinical Trial
Official title:
Trans-PBRN Case-control Study of Osteonecrosis of the Jaws
The purpose of this study was to examine risk factors for osteonecrosis of the jaw (ONJ), including the possible association with bisphosphonates (BPs). This study used the research infrastructure from the three NIDCR-funded dental practice-based research networks (DPBRN, PEARL, PRECEDENT). De-identified data from the DPBRN were merged with comparable de-identified data from PEARL and PRECEDENT to form a single trans-PBRN data set used for analysis.
The aims of this study were to (1) test the hypothesis that (BP) treatment is a risk factor for (ONJ); (2) to test the hypothesis that dental diseases (particularly periodontal disease), and invasive dental procedures such as dental extractions are true risk factors for (ONJ). ;
Observational Model: Case Control, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01666106 -
Osteonecrosis of the Jaw (ONJ) Case Registry
|
||
Not yet recruiting |
NCT06419010 -
Leukocyte- and Platelet-Rich Fibrin in the Surgical Treatment of Medication-related Osteonecrosis of the Jaw
|
N/A | |
Enrolling by invitation |
NCT05329558 -
Local and Systemic Changes in Osteonecrosis of the Jawbone
|
||
Completed |
NCT01201330 -
DPBRN Retrospective Cohort Study of Osteonecrosis of the Jaw
|
N/A | |
Completed |
NCT01967160 -
Osteonecrosis of the Jaw (ONJ) and Infection Among Nordic Cancer Patients Treated With XGEVA™ or Zoledronic Acid
|
||
Recruiting |
NCT06457776 -
Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs
|